5HT2A Receptor Binding is Increased in Borderline Personality Disorder

Biological Psychiatry

Volumn 62, Issue 6, 2007, Pages 580-587

  Soloff, Paul H ^a   Price, Julie C ^b   Meltzer, Carolyn C ^a   Fabio, Anthony ^a   Frank, Guido K ^c   Kaye, Walter H ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

18F altanserin binding; borderline personality disorder; hippocampus

Indexed keywords

SEROTONIN 2A RECEPTOR; ALTANSERIN; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORODEOXYGLUCOSE F 18; KETANSERIN;

ADULT; AGE DISTRIBUTION; AGGRESSION; ARTICLE; BORDERLINE STATE; CHILD ABUSE; CINGULATE GYRUS; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; FEMALE; HIPPOCAMPUS; HUMAN; IMPULSIVENESS; OCCIPITAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR BINDING; SUICIDAL BEHAVIOR; TEMPORAL LOBE; THALAMUS; BRAIN; CHILD; COMPARATIVE STUDY; FRONTAL LOBE; GENETICS; METABOLISM; POSITRON EMISSION TOMOGRAPHY; PSYCHOLOGICAL ASPECT; RISK FACTOR; SCINTISCANNING; STATISTICS; SUICIDE;

ADULT; AGGRESSION; BORDERLINE PERSONALITY DISORDER; BRAIN; CHILD; CHILD ABUSE; DEPRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; FRONTAL LOBE; HIPPOCAMPUS; HUMANS; IMPULSIVE BEHAVIOR; KETANSERIN; POSITRON-EMISSION TOMOGRAPHY; RECEPTOR, SEROTONIN, 5-HT2A; RISK FACTORS; SUICIDE;

EID: 34548155536     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.10.022     Document Type: Article

References (73)

1. 2A receptors in normal volunteers: Normative data and relationship to physiological and demographic variables. Neuroimage 21 (2004) 1105-1113
2. Arango V., Underwood M.D., Gubbi A.V., and Mann J.J. Localized alterations in pre-and post synaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 688 (1995) 121-133
3. Arango V., Underwood M.D., and Mann J.J. Postmortem findings in suicide victims. Implications for in vivo studies. Ann N Y Acad Sci 836 (1997) 269-287
4. 2A receptor binding index in deliberate self-harm patients. Eur J Nucl Med 28 (2001) 175-182
5. Bailer U.F., Price J.C., Meltzer C.C., Mathis C.A., Frank G.K., Weissfeld L., et al. Altered 5-HT2A receptor binding after recovery from bulimia-type anorexia nervosa: Relationships to harm avoidance and drive for thinness. Neuropsychopharmacology 29 (2004) 1143-1155
6. Barratt E.S., and Slaughter L. Defining, measuring and predicting impulsive-aggression: A heuristic model. Behav Sci Law 16 (1998) 285-302
7. Biver F., Lotstra F., Monclus M., Wikler D., Damhaut P., Mendlewicz J., and Goldman S. Sex difference in 5-HT2 receptor in the living human brain. Neurosci Lett 204 (1996) 25-28
8. Biver F., Wikler D., Lotstra F., Damhaut P., Goldman S., and Mendlewicz J. Serotonin 5-HT2 receptor imaging in major depression: Focal changes in orbito-insular cortex. Br J Psychiatry 171 (1997) 444-448
9. Brambilla P., Soloff P.H., Sala M., Nicoletti M.A., Keshavan M.S., and Soares J.C. Anatomical MRI study of borderline personality disorder patients. Psychiatry Res 131 (2004) 125-133
10. Bremner J.D. Does stress damage the brain?. Biol Psychiatry 45 (1999) 797-805
11. Bremner J.D., Vythilingam M., Vermetten E., Southwick S.M., McGlashan T., Nazeer A., et al. MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. Am J Psychiatry 160 (2003) 924-932
12. Brown G.L., and Goodwin F.K. Cerebrospinal fluid correlates of suicide attempts and aggression. Ann N Y Acad Sci 487 (1986) 175-188
13. Cheetham S.C., Crompton M.R., Katrona C.L., and Horton R.W. Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res 443 (1988) 272-280
14. Deakin J.F.K. Depression and antisocial personality disorder: Two contrasting disorders of 5HT function. J Neural Transm Suppl 64 (2003) 79-93
15. De La Fuente J.M., Goldman S., Stanus E., Vizuete C., Morlan I., Bobes J., and Mendlewicz J. Brain glucose metabolism in borderline personality disorder. J Psychiatr Res 31 (1997) 531-541
16. Donegan N.H., Sanislow C.A., Blumberg H.P., Fulbright R.K., Lacadie C., Skudlarski P., et al. Amygdala hyperreactivity in borderline personality disorder: Implications for emotional dysregulation. Biol Psychiatry 54 (2003) 1284-1293
17. Drevets W.C., Price J.L., Simpson Jr. J.R., Todd R.D., Reich T., Vannier M., and Raichle M.E. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386 (1997) 824-827
18. Driessen M., Herrmann J., Stahl K., Zwaan M., Meier S., Hill A., et al. Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization. Arch Gen Psychiatry 57 (2000) 1115-1122
19. 2A receptor mRNA in human postmortem brain using competitive RT-PCR. Neuroreport 9 (1998) 3761-3765
20. Goyer P.F., Andreason P.J., Semple W.E., Clayton A.H., King A.C., Compton-Toth B.A., et al. Positron-emission tomography and personality disorders. Neuropsychopharmacology 10 (1994) 21-28
21. Guy W (1976): ECDEU Assessment Manual of Psychopharmacology-Revised. Rockville, Maryland: U.S. Department of Health, Education, and Welfare Publ. No. ADM 76-338.
22. Herpertz S.C., Dietrich T.M., Wenning B., Krings T., Erberich S.C., Willmes K., et al. Evidence of abnormal amygdala functioning in borderline personality disorder: A functional MRI study. Biol Psychiatry 50 (2001) 292-298
23. Isomesta E.T., Henriksson M.M., Heikkinen M.E., Aro H.M., Marttunen M.J., Kuoppasalmi K.I., and Lonnqvist J.K. Suicide among subjects with personality disorders. Am J Psychiatry 153 (1996) 667-673
24. Juengling F.D., Schmahl C., Hesslinger B., Ebert D., Bremner J.D., Gostomzyk J., et al. Positron emission tomography in female patients with borderline personality disorder. J Psychiatr Res 37 (2003) 109-115
25. Kaye W.H., Frank G.K., Meltzer C.C., Price J.C., McConaha C., Crossan P.J., et al. Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa. Am J Psychiatry 158 (2001) 1152-1155
26. Koeppe R.A., Holthoff V.A., Frey K.A., Kilbourn M.R., and Kuhl D.E. Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 11 (1991) 735-744
27. Lammertsma A.A., and Hume S.P. Simplified reference tissue model for PET receptor studies. Neuroimage 4 (1996) 153-158
28. Lemaire C., Cantineau R., Guillaume M., Plenevaux A., and Christiaens L. Fluorine-18-altanserine: A radioligand for the study of serotonin receptors with PET: Radiolabeling and in vivo biologic behavior in rats. J Nucl Med 32 (1991) 2266-2272
29. Logan J., Fowler J.S., Volkow N.D., Wolf A.P., Dewey S.L., Schlyer D.J., et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10 (1990) 740-747
30. Loranger A.W., Susman V.L., Oldham J.M., and Russakoff L.M. The Personality Disorder Examination: A preliminary report. J Personal Disord 1 (1987) 1-3
31. Mann J.J., Stanley M., McBride P.A., and McEwen B.S. Increased serotonin-2 and B-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 43 (1986) 945-959
32. Mann J.J., and Stoff D.M. A synthesis of current findings regarding neurobiological correlates and treatment of suicidal behavior. Ann N Y Acad Sci 836 (1997) 352-363
33. Mann J.J., Waternaux C., Haas G.L., and Malone K.M. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 156 (1999) 181-189
34. Mason N., Huang Y., Holt J., Perevuznik B., Lopresti B., and Mathis C. Synthesis and characterization of [F-18] 4-(4fluoro-benzoyl) piperidine, an [F-18] altanserin metabolite. J Nucl Med 38 (1997) 56
35. 18F] altanserin to serotonin type 2A receptors in aging: Persistence of effect after partial volume correction. Brain Res 813 (1998) 167-171
36. Meyer J.H., McMain S., Kennedy S.H., Korman L., Brown G., DaSilva J.N., et al. Dysfunctional attitudes and 5HT2 receptors during depression and self-harm. Am J Psychiatry 160 (2003) 90-99
37. Minoshima S., Berger K.L., Lee K.S., and Mintun M.A. An automated method for rotational correction and centering of three-dimensional functional brain images. J Nucl Med 33 (1992) 1579-1585
38. Mintun M.A., Raichle M.E., Kilbourn M.R., Wooten G.F., and Welch M.J. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15 (1984) 217-227
39. 18F] altanserin positron emission tomography. Biol Psychiatry 55 (2004) 217-224
40. Moses E.L., Drevets W.C., Smith G., Mathis C.A., Kalro B.N., Butters M.A., et al. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: A PET study. Biol Psychiatry 48 (2000) 854-860
41. New A.S., Hazlett E.A., Buchsbaum M.S., Goodman M., Reynolds D., Mitropoulou V., et al. Blunted prefrontal cortical 18-Flurodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch Gen Psychiatry 59 (2002) 621-629
42. O'Leary K., Cowdry R., Gardner D., Leibenluft E., Lucas P., and de Jong-Meyer R. Dysfunctional attitudes in borderline personality disorder. J Peronal Disord 5 (1991) 233-242
43. Oquendo M.A., and Mann J.J. The biology of impulsivity and suicidality. Psychiatr Clin North Am 23 (2000) 11-27
44. Paris J., and Zweig-Frank H. A 27-year follow-up of patients with borderline personality disorder. Compr Psychiatry 42 (2001) 782-487
45. 2A receptor density in impulsive aggressive dogs with 99mTc-ECD and 123I-5-R91150. Eur J Nucl Med Mol Imaging 30 (2003) 1538-1546
46. 18F] altanserin bolus injection PET data. II. Consideration of radiolabeled metabolites in baboons. Synapse 41 (2001) 1-10
47. 18F] altanserin bolus injection PET data. II. Consideration of radiolabeled metabolites in humans. Synapse 41 (2001) 11-21
48. Rosel P., Arranz B., San L., Vallejo J., Crespo J.M., Urretavizcaya M., and Navarro M.A. Altered 5-HT(2A) binding sites and second messenger inositol triphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicides. Psychiatry Res 99 (2000) 173-181
49. Rosier A., Dupont P., Peuskens J., Bormans G., Vandenberghe R., Maes M., et al. Visualization of loss of 5-HT2a receptors with age in healthy volunteers using [18-F] altanserin and positron emission tomographic imaging. Psychiatry Res 68 (1996) 11-22
50. Runeson B. Mental disorder in youth suicide. Acta Psychiatr Scand 79 (1989) 490-497
51. Rusch N., van Elst L.T., Ludaescher P., Wilke M., Huppertz H.J., Thiel T., et al. A voxel-based morphometric MRI study in female patients with borderline personality disorder. Neuroimage 20 (2003) 385-392
52. Sadzot B., Lemaire C., Maquet P., Salmon E., Plenevaux A., Degueldre C., et al. Serotonin 5-HT2 receptor ligand imaging in the human brain using positron emission tomography and a new radioligand, [18-F] altanserin: Results in young normal controls. J Cereb Blood Flow Metab 15 (1995) 787-797
53. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57 (2000) 925-935
54. Schmahl C.G., Vermetten E., Elzinga B.M., and Bremner J.D. Magnetic resonance imaging of hippocampal and amygdala volume in women with childhood abuse and borderline personality disorder. Psychiatry Res 122 (2003) 193-198
55. Sheline Y.I., Wang P.O., Mokhtar G.H., Csernansky J.G., and Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 93 (1996) 3908-3913
56. Sheline Y.I. 3D MRI studies of neuroanatomic changes in unipolar major depression: The role of stress and medical co-morbidity. Biol Psychiatry 48 (2000) 791-800
57. Siever L.J., Buchsbaum M., New A.S., Spiegel-Cohen J., Wei T., Hazlett E., et al. d,l fenfluramine response in impulsive personality disorder assessed with [18-F] fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology 20 (1999) 413-423
58. Smith G.S., Price J.C., Lopresti B., Huang Y., Simpson N., Holt D., et al. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F] altanserin in the human brain. Synapse 30 (1998) 380-392
59. Soloff P.H., Lis J.A., Kelly T., Cornelius J., and Ulrich R. Risk factors for suicidal behavior in borderline personality disorder. Am J Psychiatry 151 (1994) 1316-1323
60. Soloff P.H., Meltzer C.C., Becker C., Greer P.J., Kelly T.M., and Constantine D. Impulsivity and prefrontal hypometabolism in borderline personality disorder. Psychiatry Res 123 (2003) 153-163
61. Soloff P.H., Meltzer C.C., Greer P.J., Constantine D., and Kelly T.M. A fenfluramine-activated FDG-PET study of borderline personality disorder. Biol Psychiatry 47 (2000) 540-547
62. Soloff PH, Nutche J, Diwadkar V (2006): Structural brain abnormalities in BPD. Paper presented at the Annual Meeting of the American Psychiatric Association, 24 May, 2006, Toronto, Canada, Syllabus abstract 91, p.108.
63. Spitzer R.L., Williams J.B.W., Gibbon M., and First M.B. Instruction Manual for the Structured Clinical Interview for DSMIII-R (1988), Biometrics Research Department, New York State Psychiatric Institute, New York
64. Staley J.K., Van Dyck C.H., Tan P.Z., Al Tikriti M., Ramsby Q., Klump H., et al. Comparison of [18 F] altanserin and [18 F] deuteroaltanserin for PET imaging of serotonin 2A receptors in baboon brain: Pharmacologic studies. Nucl Med Biol 28 (2001) 271-279
65. Stockmeier C.A. Neurobiology of serotonin in depression and suicide. Ann N Y Acad Sci 836 (1997) 220-232
66. 18F] altanserin. J Nucl Med 38 (1997) 287
67. 18F] altanserin in human and rodent. Nuclear Medicine and Biol 26 (1999) 601-608
68. Tebartz van Elst L., Hesslinger B., Thiel T., Geiger E., Haegele K., Lemieux L., et al. Frontolimbic brain abnormalities in patients with borderline personality disorder. A volumetric MRI study. Biol Psychiatry 54 (2003) 163-171
69. Vythilingham M., Heim C., Newport J., Miller A.H., Anderson E., Bronen R., et al. Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry 159 (2002) 2072-2080
70. Wall P.M., and Messier C. The hippocampal formation-orbitomedial prefrontal cortex circuit in the attentional control of active memory. Behav Brain Res 127 (2001) 99-117
71. Woods R.P., Mazziotta J.C., and Cherry S.R. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 17 (1993) 536-546
72. Zanarini M.C., Gunderson J.G., Frankenburg F.R., et al. The Revised Diagnostic Interview for Borderlines: Discriminating BPD from other Axis II disorders. J Personal Disord 3 (1989) 10-18
73. Zisook S., Goff A., Sledge P., and Shuchter S.R. Reported suicidal behavior and current suicidal ideation in a psychiatric outpatient clinic. Ann Clin Psychiatry 6 (1994) 27-31